Gottlieb Renews Call For New Opioid Review Paradigm As Democrats Prepare For House Control

Neither Kamala Harris nor Donald Trump mentioned drug pricing reforms in their presidential convention speeches.

The agency is clearly on the radar of former President Trump and his new coterie of tech moguls.

With the 4 July UK general election less than two weeks away, the Pink Sheet looks at the manifestos published by the major political parties and finds pledges to drive innovation, boost clinical trial activity and speed up regulatory procedures.

While more significant reforms are less likely under a second Biden term unless Democrats control both chambers of Congress, former President Trump could look to put his stamp on drug pricing reform by resurrecting one of his former policies involving international reference pricing and Medicare Part B drugs.